Ulrich Kragh‐Hansen

8.2k citations

116 papers · 7.1k indexed · 2 hit papers · h-index 39

Co-authors: Masaki Otagiri Victor Tuan Giam Chuang Toru Maruyama Jesper V. Møller Hiroshi Watanabe Keishi Yamasaki Lorenzo Minchiotti Monica Galliano
Topics: Protein Interaction Studies and Fluorescence Analysis (81 papers)Hemoglobin structure and function (27 papers)Drug Transport and Resistance Mechanisms (25 papers)
Cited by: Molecular Biology Oncology Spectroscopy
Journals: Journal of Biological Chemistry Journal of Molecular Biology The Journal of Physiology
Partner nations: Denmark Japan Italy

In The Last Decade

Ulrich Kragh‐Hansen

115 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular aspects of ligand binding to serum albumin.

1981 1.4k citations Ulrich Kragh‐Hansen profile →
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.

2002 774 citations Ulrich Kragh‐Hansen, Masaki Otagiri et al. profile →

Peers

Countries citing papers authored by Ulrich Kragh‐Hansen

Since Specialization

Citations

This map shows the geographic impact of Ulrich Kragh‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Kragh‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Kragh‐Hansen more than expected).

Fields of papers citing papers by Ulrich Kragh‐Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Kragh‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Kragh‐Hansen. The network helps show where Ulrich Kragh‐Hansen may publish in the future.

Co-authorship network of co-authors of Ulrich Kragh‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Kragh‐Hansen. A scholar is included among the top collaborators of Ulrich Kragh‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Kragh‐Hansen. Ulrich Kragh‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Possible Mechanisms by Which Enzymatic Degradation of Human Serum Albumin Can Lead to Bioactive Peptides and Biomarkers 2018 ·Frontiers in Molecular Biosciences ·Ulrich Kragh‐Hansen	16
2	Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemia 2016 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Ulrich Kragh‐Hansen,Lorenzo Minchiotti,Andrea Coletta,(unknown),Monica Galliano,Birgit Schiøtt,Yasunori Iwao,Yu Ishima,Masaki Otagiri	10
3	An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencing 2016 ·Journal of Controlled Release ·(unknown),Michael Lykke Hvam,Malgorzata Maria Pakula,Frederik Dagnæs‐Hansen,Jesper Wengel,Birgitte M. Malle,Ulrich Kragh‐Hansen,Jason Cameron,(unknown),Kenneth A. Howard	32
4	Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants 2015 ·Life Sciences ·Makoto Anraku,(unknown),Kazuaki Taguchi,Ulrich Kragh‐Hansen,Toshiya Kai,Toru Maruyama,Masaki Otagiri	37
5	Human serum albumin isoforms: Genetic and molecular aspects and functional consequences 2013 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Ulrich Kragh‐Hansen,Lorenzo Minchiotti,Monica Galliano,Theodore Peters	59
6	Congenital analbuminaemia: Molecular defects and biochemical and clinical aspects 2013 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Lorenzo Minchiotti,Monica Galliano,Gianluca Caridi,Ulrich Kragh‐Hansen,Theodore Peters	26
7	S-Nitrosated Human Serum Albumin Dimer is not only a Novel Anti-Tumor Drug but also a Potentiator for Anti-Tumor Drugs with Augmented EPR Effects 2012 ·Bioconjugate Chemistry ·Yu Ishima,Di Chen,Jun Fang,Hiroshi Maeda,(unknown),Ulrich Kragh‐Hansen,Toshiya Kai,Toru Maruyama,Masaki Otagiri	45
8	Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin 2010 ·Journal of Structural Biology ·Kim L. Hein,Ulrich Kragh‐Hansen,Jens Preben Morth,Martin D. Jeppesen,Daniel E. Otzen,Jesper V. Møller,Poul Nissen	99
9	Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin 2008 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Yasunori Iwao,(unknown),Ulrich Kragh‐Hansen,Keiichi Kawai,Ayaka Suenaga,Toru Maruyama,Masaki Otagiri	14
10	Mutations and polymorphisms of the gene of the major human blood protein, serum albumin 2008 ·Human Mutation ·Lorenzo Minchiotti,Monica Galliano,Ulrich Kragh‐Hansen,Theodore Peters	50
11	Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation 2007 ·Biochemical and Biophysical Research Communications ·Yu Ishima,Takaaki Akaike,Ulrich Kragh‐Hansen,(unknown),Tomohiro Sawa,Toru Maruyama,Toshiya Kai,Masaki Otagiri	22
12	Rate-of-dialysis technique: Theoretical and practical aspects 2005 ·Analytical Biochemistry ·Ulrich Kragh‐Hansen,(unknown),Anders Overgaard Pedersen	10
13	Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin 2004 ·Clinica Chimica Acta ·Ulrich Kragh‐Hansen,Monica Campagnoli,Slavica Dodig,H.L. Nielsen,Bojan Benko,(unknown),(unknown),Alberto Sala,Monica Galliano,Lorenzo Minchiotti	12
14	Esterase-Like Activity of Serum Albumin: Characterization of Its Structural Chemistry Using p-Nitrophenyl Esters as Substrates 2004 ·Pharmaceutical Research ·Yuji Sakurai,(unknown),Hiroshi Watanabe,Noriyuki Yamaotsu,Shuichi Hirono,Yukihisa Kurono,Ulrich Kragh‐Hansen,Masaki Otagiri	116
15	Effect of Oxidative Stress on the Structure and Function of Human Serum Albumin 2001 ·Pharmaceutical Research ·Makoto Anraku,Keishi Yamasaki,Toru Maruyama,Ulrich Kragh‐Hansen,Masaki Otagiri	118
16	Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin 1999 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Lorenzo Minchiotti,Ulrich Kragh‐Hansen,H.L. Nielsen,Elisabeth Hardy,(unknown),Monica Galliano	14
17	Transitional steps in the solubilization of protein-containing membranes and liposomes by nonionic detergent 1993 ·Biochemistry ·Ulrich Kragh‐Hansen,Marc le Maire,(unknown),Tadeusz Gulik‐Krzywicki,(unknown)	85
18	A Micromethod for Delipidation of Aqueous Proteins 1993 ·Analytical Biochemistry ·Ulrich Kragh‐Hansen	18
19	Solubility of long-chain fatty acids in phosphate buffer at pH 7.4 1992 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Henrik Vorum,Rolf Brodersen,Ulrich Kragh‐Hansen,Anders Overgaard Pedersen	119
20	Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. 1988 ·Molecular Pharmacology ·Ulrich Kragh‐Hansen	123

About Ulrich Kragh‐Hansen

Ulrich Kragh‐Hansen is a scholar working on Cell Biology, Molecular Biology and Spectroscopy, having authored 116 papers that have together received 7.1k indexed citations. Recurring topics across this work include Protein Interaction Studies and Fluorescence Analysis (81 papers), Hemoglobin structure and function (27 papers) and Drug Transport and Resistance Mechanisms (25 papers). The work is most often cited by research in Molecular Biology (5.4k citations), Oncology (2.1k citations) and Spectroscopy (934 citations). Ulrich Kragh‐Hansen has collaborated with scholars based in Denmark, Japan and Italy. Frequent co-authors include Masaki Otagiri, Victor Tuan Giam Chuang, Toru Maruyama, Jesper V. Møller, Hiroshi Watanabe, Keishi Yamasaki, Lorenzo Minchiotti, Monica Galliano, Keisuke Nakajou and M I Sheikh. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology and The Journal of Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact